Clinical Trial Update: Olmesartan in Essential Hypertension [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating olmesartan for essential hypertension has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Essential Hypertension

Drugs mentioned

• Olmesartan (olmesartan)

Snippet

Sponsor: Sankyo Pharma Gmbh | Conditions: Essential Hypertension | Phase 3 | Status: COMPLETED